Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Wujiang Biopharmaceutical is a specialized manufacturer of biochemical active pharmaceutical ingredients (APIs) and intermediates based in Suzhou, China. Established in 1970, the company has developed significant expertise in the extraction and purification of animal-derived products, most notably heparin sodium and chondroitin sulfate. Their facilities are designed to meet global regulatory standards, including GMP certifications, enabling them to supply active ingredients to pharmaceutical companies worldwide. In addition to its core API business, the company produces various enzymes such as chymotrypsin and trypsin for clinical and industrial use. The firm operates as a key supplier in the global supply chain for anticoagulants and musculoskeletal health products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wujiang Bio-pharm.